hot flashes with semaglutide Ozempic and Flushes: Causes, Management, and When to Seek Help Still Getting Hot Flashes? |

doi: 10.1016/j.pbb.2004.07.014

In this way, the "liver filter" is skipped and the first-pass metabolism that usually occurs in the liver is avoided, which deactivates a large part of the Glutathione molecule, making it less functional and effective

Mojsov S

What we know: Retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously Phase 2/3 trials show 24-29% weight loss at highest doses Side effects are similar to other incretin medications (mainly GI) It may be particularly effective for liver fat reduction FDA approval is potentially years away What to consider: Approved alternatives (semaglutide, tirzepatide) have established safety profiles "GLP-3" marketing may oversimplify or mislead Investigational drugs carry unknown long-term risks Quality control for compounded versions is variable Clinical trial results don't always translate to real-world outcomes The bigger picture: Retatrutide may represent a genuine advance in obesity treatmentthe data is genuinely impressive

119,120 Additionally, post-marketing data indicate that the apparent risk for amputation was again related to sensor change and enhanced monitoring and that there are equal outcomes overall between SGLT2 inhibitors and GLP-1 RAs